Cargando…

Identification of disease-related aberrantly spliced transcripts in myeloma and strategies to target these alterations by RNA-based therapeutics

Novel drug discoveries have shifted the treatment paradigms of most hematological malignancies, including multiple myeloma (MM). However, this plasma cell malignancy remains incurable, and novel therapies are therefore urgently needed. Whole-genome transcriptome analyses in a large cohort of MM pati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ogiya, Daisuke, Chyra, Zuzana, Verselis, Sigitas J., O’Keefe, Morgan, Cobb, Jacquelyn, Abiatari, Ivane, Talluri, Srikanth, Sithara, Anjana Anilkumar, Hideshima, Teru, Chu, Michael P., Hájek, Roman, Dorfman, David M., Pilarski, Linda M., Anderson, Kenneth C., Adamia, Sophia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9898564/ https://www.ncbi.nlm.nih.gov/pubmed/36737429 http://dx.doi.org/10.1038/s41408-023-00791-0

Ejemplares similares

Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma
por: Adamia, Sophia, et al.
Publicado: (2022)

Author Correction: Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma
por: Adamia, Sophia, et al.
Publicado: (2022)

PB2397: TRANSCRIPTOME ANALYSIS OF DIFFUSE LARGE B-CELL LYMPHOMA CELLS EXPRESSING MYD88 L265P REVEALS CD44, LGALS3, NFKBIZ AND BATF AS DOWNSTREAM TARGETS OF ONCOGENIC NF-ΚB SIGNALING.
por: Turi, Marcello, et al.
Publicado: (2023)

Transcriptome Analysis of Diffuse Large B-Cell Lymphoma Cells Inducibly Expressing MyD88 L265P Mutation Identifies Upregulated CD44, LGALS3, NFKBIZ, and BATF as Downstream Targets of Oncogenic NF-κB Signaling
por: Turi, Marcello, et al.
Publicado: (2023)

P805: EXTRAMEDULLARY MULTIPLE MYELOMA: MOLECULAR PATHOGENESIS AND NOVEL THERAPEUTIC TARGETS
por: Zihala, David, et al.
Publicado: (2023)

Immunomodulatory drugs activate NK cells via both Zap-70 and cereblon-dependent pathways
por: Hideshima, Teru, et al.
Publicado: (2020)

Signaling Pathway Mediating Myeloma Cell Growth and Survival
por: Hideshima, Teru, et al.
Publicado: (2021)

Aberrant Cx26 hemichannels and keratitis-ichthyosis-deafness syndrome: insights into syndromic hearing loss
por: Sanchez, Helmuth A., et al.
Publicado: (2014)

Gallbladder agenesis: A case report and review of the literature
por: Pipia, Irakli, et al.
Publicado: (2018)

The State of Public Health Education and Science During and After the Fall of the Soviet Union: Achievements, Remaining Challenges, and Future Priorities
por: Gotsadze, George, et al.
Publicado: (2022)

Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine
por: Zátopková, Martina, et al.
Publicado: (2022)

The biological significance of histone modifiers in multiple myeloma: clinical applications
por: Ohguchi, Hiroto, et al.
Publicado: (2018)

PRMT5 inhibitors on the (myeloma) road
por: Gulla, Annamaria, et al.
Publicado: (2018)

Author Correction: The biological significance of histone modifiers in multiple myeloma: clinical applications
por: Ohguchi, Hiroto, et al.
Publicado: (2021)

IKKβ inhibitor in combination with bortezomib induces cytotoxicity in breast cancer cells
por: HIDESHIMA, HIROMASA, et al.
Publicado: (2014)

Moesin-dependent cytoskeleton remodelling is associated with an anaplastic phenotype of pancreatic cancer
por: Abiatari, Ivane, et al.
Publicado: (2010)

Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancer
por: Li, Junsheng, et al.
Publicado: (2005)

Syndecan-2 promotes perineural invasion and cooperates with K-ras to induce an invasive pancreatic cancer cell phenotype
por: De Oliveira, Tiago, et al.
Publicado: (2012)

Benign osteoblastoma of the mandible in a 12-year-old female: A case report
por: MARDALEISHVILI, KONSTANTINE, et al.
Publicado: (2014)

Heterogeneity of B cell lymphopoiesis in patients with premalignant and active myeloma
por: Jakubikova, Jana, et al.
Publicado: (2023)

A review of lenalidomide in combination with dexamethasone for the treatment of multiple myeloma
por: Hideshima, Teru, et al.
Publicado: (2008)

More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia–Like Multiple Myeloma
por: Jelinek, Tomas, et al.
Publicado: (2023)

GlyPerA™ effectively shields airway epithelia from SARS-CoV-2 infection and inflammatory events
por: Zaderer, Viktoria, et al.
Publicado: (2023)

iCOMIC: a graphical interface-driven bioinformatics pipeline for analyzing cancer omics data
por: Anilkumar Sithara, Anjana, et al.
Publicado: (2022)

Alteration of Introns in a Hyaluronan Synthase 1 (HAS1) Minigene Convert Pre-Mrna Splicing to the Aberrant Pattern in Multiple Myeloma (MM): MM Patients Harbor Similar Changes
por: Kriangkum, Jitra, et al.
Publicado: (2013)

Current practice in mammographic imaging of the augmented breast in Australia
por: O'Keefe, Jacquelyn R, et al.
Publicado: (2020)

Correction: Alteration of Introns in a Hyaluronan Synthase 1 (HAS1) Minigene Convert Pre-mRNA Splicing to the Aberrant Pattern in Multiple Myeloma (MM): MM Patients Harbor Similar Changes
por: Kriangkum, Jitra, et al.
Publicado: (2013)

Newly designed 11-gene panel reveals first case of hereditary amyloidosis captured by massive parallel sequencing
por: Chyra Kufova, Zuzana, et al.
Publicado: (2018)

Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility
por: Celichowski, Piotr, et al.
Publicado: (2023)

529 Prevalence of Bronchitis and Revealing of the Risk Factors in the Children's Population
por: Adamia, Nino, et al.
Publicado: (2012)

A novel 3D mesenchymal stem cell model of the multiple myeloma bone marrow niche: biologic and clinical applications
por: Jakubikova, Jana, et al.
Publicado: (2016)

In Vitro Evaluation of the Therapeutic Potential of Phage VA7 against Enterotoxigenic Bacteroides fragilis Infection
por: Bakuradze, Nata, et al.
Publicado: (2021)

ERK signaling mediates resistance to immunomodulatory drugs in the bone marrow microenvironment
por: Liu, Jiye, et al.
Publicado: (2021)

Lenalidomide in multiple myeloma: an evidence-based review of its role in therapy
por: Richardson, Paul, et al.
Publicado: (2010)

Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis
por: Chyra, Zuzana, et al.
Publicado: (2020)

The NineTeen Complex (NTC) and NTC-associated proteins as targets for spliceosomal ATPase action during pre-mRNA splicing
por: de Almeida, Rogerio Alves, et al.
Publicado: (2015)

The U1, U2 and U5 snRNAs crosslink to the 5′ exon during yeast pre-mRNA splicing
por: McGrail, Joanne C., et al.
Publicado: (2008)

Aberrant T cell differentiation in the absence of Dicer
por: Muljo, Stefan A., et al.
Publicado: (2005)

Mutation of the LXCXE Binding Cleft of pRb Facilitates Transformation by ras In Vitro but Does Not Promote Tumorigenesis In Vivo
por: Talluri, Srikanth, et al.
Publicado: (2013)

The Human-Canine Bond: A Heart's Best Friend
por: O'Keefe, James H., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4ag0e9gvpklbokcq8bjdths4bs